Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Profit Margin (Quarterly): -40.51% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -40.51% |
| June 30, 2023 | 5.25% |
| March 31, 2023 | -132.1% |
| December 31, 2022 | -450.5% |
| September 30, 2022 | -85.48% |
| June 30, 2022 | -209.0% |
| March 31, 2022 | -344.1% |
| December 31, 2021 | -498.3% |
| September 30, 2021 | -372.0% |
| June 30, 2021 | -287.2% |
| March 31, 2021 | -685.3% |
| December 31, 2020 | -151.6% |
| Date | Value |
|---|---|
| September 30, 2020 | -341.8% |
| June 30, 2020 | -459.5% |
| March 31, 2020 | -380.7% |
| December 31, 2019 | -638.7% |
| September 30, 2019 | -1.12K% |
| June 30, 2019 | -1.11K% |
| March 31, 2019 | -1.28K% |
| December 31, 2018 | -917.2% |
| September 30, 2018 | -635.8% |
| June 30, 2018 | -563.9% |
| March 31, 2018 | -312.3% |
| December 31, 2017 | -697.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.12K%
Minimum
Sep 2019
5.25%
Maximum
Jun 2023
-405.9%
Average
-358.1%
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 30.19% |
| Axonics Inc | -20.91% |
| Johnson & Johnson | 15.22% |
| Boston Scientific Corp | 12.76% |
| Ambrx Biopharma Inc (DELISTED) | -43.38K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -498.9% |
| Return on Assets | -43.72% |
| Return on Invested Capital | -498.9% |
| Operating Margin (Quarterly) | -272.9% |
| Return on Net Operating Assets | -200.1% |